Patent Application
Utility
App. No. 17/063,470
· Confirmation No. 9541
USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-09-30 | ABN |
Abandonment | 2 | View | |
| 2022-09-19 | XT/ |
Extension of Time | 1 | View | |
| 2022-09-19 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-09-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-03-25 | OA.POSTCARD |
A courtesy postcard sent by USPTO to users who opt-in for e-Office Action | 1 | View | |
| 2022-03-17 | CTNF |
Non-Final Rejection | 12 | View | |
| 2022-03-17 | 892 |
List of references cited by examiner | 1 | View | |
| 2022-03-17 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2022-03-17 | SRNT |
Examiner's search strategy and results | 1 | View | |
| 2022-03-17 | BIB |
Bibliographic Data Sheet | 2 | View | |
| 2022-03-17 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2022-03-17 | FOR |
Foreign Reference | 83 | View | |
| 2021-04-29 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2021-01-19 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-01-19 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-01-14 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2021-01-14 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-01-14 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2021-01-14 | XT/ |
Extension of Time | 1 | View | |
| 2021-01-14 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2021-01-14 | CLM |
Claims | 5 | View | |
| 2021-01-14 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2020-10-15 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2020-10-15 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2020-10-15 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2020-10-08 | PA.. |
Power of Attorney | 1 | View | |
| 2020-10-08 | PA.. |
Power of Attorney | 1 | View | |
| 2020-10-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-10-05 | TRNA |
Transmittal of New Application | 1 | View | |
| 2020-10-05 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2020-10-05 | ADS |
Application Data Sheet | 10 | View | |
| 2020-10-05 | DRW.NONBW |
Drawings-other than black and white line drawings | 26 | View | |
| 2020-10-05 | OATH |
Oath or Declaration filed | 1 | View | |
| 2020-10-05 | OATH |
Oath or Declaration filed | 1 | View | |
| 2020-10-05 | SPEC |
Specification | 103 | View | |
| 2020-10-05 | CLM |
Claims | 5 | View | |
| 2020-10-05 | ABST |
Abstract | 1 | View | |
| 2020-10-05 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2020-10-05 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Jonathan Moss
Chicago, IL
Lorin K. Johnson
Los Altos Hills, CA
Attorneys & Agents of Record
Classification
USPC
514/289
A61K31/485
A61P1/10
A61P35/00
A61B5/4848
A61K9/0053
A61K9/20
A61K45/06
A61K49/0004
Prosecution
- Examiner
- MCMILLIAN, KARA RENITA
- Art Unit
- 1627
- Customer No.
- 75093
- Docket No.
- 119557-11906
- Confirmation No.
- 9541
Publication
- Pub. No.
- US20210121456A1
- Pub. Date
- 2021-04-29
Parent
is a Continuation of
→
App. 16/667,300
Filed 2019-10-29
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 15/477,724
Filed 2017-04-03
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a Continuation of
→
PCT/US2015/056060
Filed 2015-10-16
· Abandoned -- Failure to Respond to an Office Action
Parent
Claims priority from a provisional application
→
App. 62/222,746
Filed 2015-09-23
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/140,876
Filed 2015-03-31
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/065,550
Filed 2014-10-17
· Provisional Application Expired
Child
is a Continuation of
→
App. 17/947,715
Filed 2022-09-19
· Abandoned -- Failure to Respond to an Office Action
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH US, LLC,
SOLTA MEDICAL, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH AMERICAS, INC.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-10-05
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-10-04
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT
Recorded 2022-02-10
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH US, LLC,
BAUSCH+LOMB IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.
SECURITY INTEREST
Recorded 2021-08-25
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH US, LLC,
BAUSCH+LOMB IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.
SECURITY INTEREST
Recorded 2021-08-25
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2021-06-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH+LOMB IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.
SECURITY INTEREST
Recorded 2021-03-29
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH+LOMB IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.
SECURITY INTEREST
Recorded 2021-03-29
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/063,470
- Filed
- 2020-10-05
- Pub. No.
- US20210121456A1
- Examiner
- MCMILLIAN, KARA RENITA
- Art Unit
- 1627
External Links